Previous Section
Clinical Trials
110. Phase III study of gemcitabine and cisplatin with or without aprinocarsen, a protein kinase C-alpha antisense oligonucleotide, in patients with advanced-stage non-small-cell lung cancer.
- Author
- Paz-Ares L; Douillard JY; Koralewski P; Manegold C; Smit EF; Reyes JM; Chang GC; John WJ; Peterson PM; Obasaju CK; Lahn M; Gandara DR;
- Institution
- Servicio de Oncologia Medica, Doce de Octubre University Hospital, Madrid, Spain. lpaz.hdoc@salud.madrid.org
- Journal
- J Clin Oncol. 2006 Mar 20;24(9):1428-34.
- Abstract URL
- Click here to view abstract
111. Gefitinib therapy in advanced bronchioloalveolar carcinoma: Southwest Oncology Group Study S0126.
- Author
- West HL; Franklin WA; McCoy J; Gumerlock PH; Vance R; Lau DH; Chansky K; Crowley JJ; Gandara DR;
- Institution
- Swedish Cancer Institute/Puget Sound Oncology Consortium, Seattle, WA, USA.
- Journal
- J Clin Oncol. 2006 Apr 20;24(12):1807-13.
- Abstract URL
- Click here to view abstract
112. Front-line paclitaxel and topotecan chemotherapy in advanced or metastatic non-small-cell lung cancer: a phase II trial.
- Author
- Stathopoulos GP; Katis C; Tsavdaridis D; Dimitroulis J; Karaindros D; Stathopoulos J; Dimou E;
- Institution
- First Oncology Department, Errikos Dunant Hospital, Athens, Greece. dr-gps@ath.forthnet.gr
- Journal
- Cancer Chemother Pharmacol. 2006 Oct;58(4):555-60. Epub 2006 Mar 7.
- Abstract URL
- Click here to view abstract
113. Docetaxel and mitomycin as second-line treatment in advanced non-small cell lung cancer.
- Author
- Feliu J; Martin G; Castro J; Sundlov A; Rodriguez-Jaraiz A; Casado E; Lomas M; Madronal C; Galan A; Belda C; Gonzalez-Baron M;
- Institution
- Servicio de Oncologia Medica, Hospital Universitario La Paz, Paseo de la Castellana 261, 28046, Madrid, Spain. jaimefeliu@hotmail.com
- Journal
- Cancer Chemother Pharmacol. 2006 Oct;58(4):527-31. Epub 2006 Mar 23.
- Abstract URL
- Click here to view abstract
Next: Radiation Therapy
